Cargando…
Clinical Circulating Tumor DNA Testing for Precision Oncology
Circulating tumor DNA (ctDNA) is the portion of the cell-free DNA in the blood of cancer patients released from tumor cells via apoptosis, necrosis, or active release. From 10 mL of blood, the 4–5 mL of plasma obtained from a cancer patient contains 5–10 ng/mL of ctDNA. The plasma contains not only...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Cancer Association
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101787/ https://www.ncbi.nlm.nih.gov/pubmed/36915242 http://dx.doi.org/10.4143/crt.2022.1026 |